about
Tensor GSVD of patient- and platform-matched tumor and normal DNA copy-number profiles uncovers chromosome arm-wide patterns of tumor-exclusive platform-consistent alterations encoding for cell transformation and predicting ovarian cancer survivalGSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survivalCD133 antigen expression in ovarian cancerSAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in NigeriaA long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophreniaCapecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trialTreatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin forIs lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?How to handle mortality when investigating length of hospital stay and time to clinical stabilityFibrogenic potential of intratracheally instilled quartz, ferric oxide, fibrous glass, and hydrated alumina in hamstersMedical adjuvant treatment to increase patency of arteriovenous fistulae and graftsChemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancerReducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysisMedical adjuvant treatment to increase patency of arteriovenous fistulae and graftsChemotherapy and supportive care versus supportive care alone in advanced non-small cell lung cancerAdjuvant chemotherapy for invasive bladder cancer (individual patient data)Postoperative radiotherapy for non-small cell lung cancerNeoadjuvant chemotherapy for locally advanced cervix cancerNeo-adjuvant chemotherapy for invasive bladder cancerPostoperative radiotherapy for non-small cell lung cancerDysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasisHigher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistanceHuman kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancerLow expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrenceThe androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancerImplications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaImmunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarkerTrends in premarital sex in the United States, 1954-2003Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumorsYoung age: an independent risk factor for disease-free survival in women with operable breast cancerRelationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinomaAkt kinases in breast cancer and the results of adjuvant therapyThymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapyExpense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagusBaclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancerExpression and prognostic significance of lysozyme in male breast cancer.Design of Phase II cancer trials evaluating survival probabilitiesLong-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone: studied by lognormal and Kaplan-Meier survival methodsSurvival of patients with metastatic breast cancer: twenty-year data from two SEER registries
P2860
Q21090556-377C3C1F-742B-4A82-AB58-B76899E2CA7FQ21090956-D8CA644E-92EA-4888-8F4A-83D03872693BQ21093306-ADAE0877-06B5-4BC2-8618-6277F03B1115Q21144355-7CBD105E-EA9F-419E-BDEE-B139B9B7DD6BQ21260310-7E132EE3-3DB5-4044-AB31-22F05CF1D056Q21260391-AEFC0074-3C3B-417F-ACFF-147AE28F29B0Q21261297-EDCB7BCC-0A63-452E-92AC-EBD5863B1278Q21261320-C140F5E9-C4EA-489D-9B25-9D2F91DA199CQ23913313-DB3BDF97-7DC3-4FC4-9126-F0EB2C5B9DE3Q23920416-A99120D0-3B42-42A0-99B5-504FE23D1876Q24186417-5DEFE851-67C4-42ED-9DBD-F636084F652BQ24235422-D9E57F1F-D5D3-4610-8BDA-A58E8CA60E39Q24240382-B31C1CFD-4FD7-4969-8DBD-453775C27676Q24241276-1B9D7F53-9B05-4B5F-AC83-D70D918D6109Q24242523-E9752F21-9249-4978-B668-2AEDDB770DADQ24243900-D7E487F2-8B52-479A-AF50-BDE7929C676BQ24243991-447D239D-9F2A-47AC-B4C3-C0000F3457DEQ24247192-8D4FCDDF-E9A4-4A81-8F11-7AAFD8F0161EQ24247506-D24305A3-537E-40C6-A680-E394D4FFEAD3Q24250253-2EAC6751-DFB3-40B4-A749-6712D4C095CEQ24292072-C01F3C8B-8DE7-4DB7-9293-17025C9FCE2BQ24642804-D8561EB0-65C8-4635-AFB5-8980D4C16C25Q24642830-31B3E31F-16AE-4DF6-9825-772119C85BDDQ24645961-04A5F889-1030-4B68-A762-F4F49FF50FF4Q24646770-6B8DF381-53ED-4E21-8FE5-1F94AEC409B1Q24647476-7040350C-4231-4E38-B008-CDBF002ECFAEQ24648238-2C55BCB0-9497-4937-8C24-E0CCD53A0AEAQ24670584-5F923BEF-6C99-4FD5-9F5F-509D4BC737E4Q24791041-DC215FCA-0735-4FBB-8BC8-A9FE6FB18A69Q24791855-13C56131-1CE3-4011-9574-38B5034216CCQ24795015-F31CCA84-0159-427E-8228-119680355F3FQ24795435-3897DBDF-73CB-47DB-9AF7-FB9329664A7DQ24795468-C71505C1-7130-4F30-83BD-32C95B509390Q24796779-67BFCBFA-07D0-4276-8D8A-213759B019DBQ24799720-9082E938-2007-4EC7-8A7D-9924D529E5D4Q24799908-C8383AA2-C51E-4A78-BE6F-F302E3FC74CAQ24800181-D79C435E-2642-444F-8A52-BEB09BC3F690Q24802587-63D1BA0A-02F4-4D33-93C2-346D70964380Q24804358-64013A12-D198-43E3-B263-B8CB7124BD23Q24806397-AD7F676D-C600-4721-8EFA-522397653544
P2860
description
1958 nî lūn-bûn
@nan
1958 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1958 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1958年の論文
@ja
1958年論文
@yue
1958年論文
@zh-hant
1958年論文
@zh-hk
1958年論文
@zh-mo
1958年論文
@zh-tw
1958年论文
@wuu
name
Nonparametric Estimation from Incomplete Observations
@ast
Nonparametric Estimation from Incomplete Observations
@en
type
label
Nonparametric Estimation from Incomplete Observations
@ast
Nonparametric Estimation from Incomplete Observations
@en
prefLabel
Nonparametric Estimation from Incomplete Observations
@ast
Nonparametric Estimation from Incomplete Observations
@en
P3181
P1476
Nonparametric Estimation from Incomplete Observations
@en
P2093
E. L. Kaplan
Paul Meier
P304
P3181
P356
10.1080/01621459.1958.10501452
P407
P577
1958-06-01T00:00:00Z